[Breast cancer after mantle field irradiation for Hodgkin's disease].
Effective use of modern therapeutic modalities results in the cure of 75%-80% of Hodgkin's disease patients, regardless of stage. The major threat to continued survival is, therefore, not recurrent disease but development of second malignancies. Recent reports have firmly established the increased risk of breast cancer developing in women treated with mantle field irradiation. We describe 3 women who developed breast carcinoma following mantle field irradiation for Hodgkin's disease. Their clinical course was consistent with that reported in larger series. They were relatively young when irradiated and there was a long interval between radiation therapy and the diagnosis of breast cancer. Review of the literature shows that there may be a role for prophylactic mastectomy after irradiation for Hodgkin's disease.
Katz
A
A
Oncology Institute, Rabin Medical Center, Petah Tikva.
Brenner
B
B
Sulkes
A
A
Luria
H
H
Marshak
G
G
Fenig
E
E
D000328:Adult; D001943:Breast Neoplasms / Q000209:etiology* / Q000601:surgery; D005260:Female; D006689:Hodgkin Disease / Q000532:radiotherapy*; D006801:Humans; D009381:Neoplasms, Radiation-Induced / Q000209:etiology* / Q000601:surgery; D016609:Neoplasms, Second Primary / Q000209:etiology* / Q000601:surgery; D011878:Radiotherapy / Q000009:adverse effects*